Abstract
An improved RP- HPLC method with PDA detection has been developed and validated for the simultaneous estimation of artemisinin and dexamethasone in ocular nanodispersion formulations and it has been successfully adopted to check the ex-vivo corneal transport. The chromatographic separation was achieved using phenomenex C18 column (250 × 4.6 mm, 5 µm) analytical column and the mobile phase consisting of acetonitrile: (methanol : water, 4: 6) mixture at the ratio of 45: 55, v/v at a flow rate of 1.0 mL/min and injection volume of 200 µl. The column temperature was maintained at 50°C. The UV detection was carried out at 219 nm using photodiode array detector. The retention times of dexamethasone and artemisinin were found to be 4.5 and 7.9 minutes respectively. Artemisinin and dexamethasone calibration curves were found to be linear with correlation coefficient of 0.9617 and 0.9954 respectively at a dynamic concentration ranging from 250ng/mL to 1250 ng/mL. Recovery was between the ranges of 98.9% - 116.8% for both artemisinin and dexamethasone. The developed method is very selective as both peaks were well separated with a short analysis time of 10 minutes and does not require any preliminary treatment of sample.
Keywords: Artemisinin, dexamethasone, RP- HPLC, quantification, nanodispersions.
Current Pharmaceutical Analysis
Title:Simultaneous Estimation of Artemisinin and Dexamethasone in Nanodispersions and Assessment of Ex-vivo Corneal Transport Study by RP- HPLC
Volume: 10 Issue: 1
Author(s): Chandrasekar Ponnusamy, Venkateshwaran Krishnaswami, Abimanyu Sugumaran and Subramanian Natesan
Affiliation:
Keywords: Artemisinin, dexamethasone, RP- HPLC, quantification, nanodispersions.
Abstract: An improved RP- HPLC method with PDA detection has been developed and validated for the simultaneous estimation of artemisinin and dexamethasone in ocular nanodispersion formulations and it has been successfully adopted to check the ex-vivo corneal transport. The chromatographic separation was achieved using phenomenex C18 column (250 × 4.6 mm, 5 µm) analytical column and the mobile phase consisting of acetonitrile: (methanol : water, 4: 6) mixture at the ratio of 45: 55, v/v at a flow rate of 1.0 mL/min and injection volume of 200 µl. The column temperature was maintained at 50°C. The UV detection was carried out at 219 nm using photodiode array detector. The retention times of dexamethasone and artemisinin were found to be 4.5 and 7.9 minutes respectively. Artemisinin and dexamethasone calibration curves were found to be linear with correlation coefficient of 0.9617 and 0.9954 respectively at a dynamic concentration ranging from 250ng/mL to 1250 ng/mL. Recovery was between the ranges of 98.9% - 116.8% for both artemisinin and dexamethasone. The developed method is very selective as both peaks were well separated with a short analysis time of 10 minutes and does not require any preliminary treatment of sample.
Export Options
About this article
Cite this article as:
Ponnusamy Chandrasekar, Krishnaswami Venkateshwaran, Sugumaran Abimanyu and Natesan Subramanian, Simultaneous Estimation of Artemisinin and Dexamethasone in Nanodispersions and Assessment of Ex-vivo Corneal Transport Study by RP- HPLC, Current Pharmaceutical Analysis 2014; 10 (1) . https://dx.doi.org/10.2174/157341291001140102111031
DOI https://dx.doi.org/10.2174/157341291001140102111031 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Activating Receptors of Natural Killer Cells and Their Inter-Switching Potentials
Current Drug Targets Use of Lactobacilli and their Pheromone-Based Regulatory Mechanism in Gene Expression and Drug Delivery
Current Pharmaceutical Biotechnology Oncostatin M: Potential Implications for Malignancy and Metabolism
Current Pharmaceutical Design Discovery and Hit to Lead Optimization of Novel Combretastatin A-4 Analogues: Dependence of C-Linker Length and Hybridization
Anti-Cancer Agents in Medicinal Chemistry Green Synthesis of Metal and Metal-oxide Nanoparticles Pertinent to <i>Catharanthus roseus</i> and <i>Moringa oleifera</i> - A Review
Current Nanomaterials The Association between Tumor-associated Macrophages and Glioblastoma: A Potential Target for Therapy
Current Pharmaceutical Design The Applications of Targeting Anti-Cancer Agents in Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Folate Based Radiopharmaceuticals for Imaging and Therapy of Cancer and Inflammation
Current Pharmaceutical Design Natural Products as Promising Antitumoral Agents in Breast Cancer: Mechanisms of Action and Molecular Targets.
Mini-Reviews in Medicinal Chemistry Role of Physician Gender in the Quality of Care of Cardiometabolic Diseases
Current Pharmaceutical Design New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics
Current Topics in Medicinal Chemistry Pharmaceutical and Biomedical Potential of PEGylated Dendrimers
Current Pharmaceutical Design An Insight of Molecular Mechanisms and Patents of Biomarkers of Human Papilloma Virus Associated with Cancer : A Review
Recent Patents on Biomarkers Apoptotic Cell Death in Bronchopulmonary Dysplasia
Current Pediatric Reviews Lipid based Nanocapsules: A Multitude of Biomedical Applications
Current Pharmaceutical Biotechnology Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women
Recent Patents on Anti-Cancer Drug Discovery Withdrawal Notice: Electrophoresis as a Tool for Early Cancer Diagnosis
Anti-Cancer Agents in Medicinal Chemistry Potential MicroRNA Targets for Cancer Chemotherapy
Current Medicinal Chemistry Bone Target Radiotracers for Palliative Therapy of Bone Metastases
Current Medicinal Chemistry Targeting Neuronal Nicotinic Receptors in Cancer: New Ligands and Potential Side-Effects
Recent Patents on Anti-Cancer Drug Discovery